
|Articles|June 1, 2003
More patients can try presbyopia reversal
The FDA will allow an increase in the number of clinical trial patients eligible to be treated for presbyopia with SurgiLight's OptiVision system.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025: Advancements in laser refractive surgery
2
From then to next: Five decades of transformation in ophthalmology
3
Kodiak Sciences releases follow-up, 20-week data from APEX study
4
Opus Genetics has Type B RMAT meeting with FDA for its gene therapy candidate, OPGx-LCA5
5


















































.png)


